In the mass spectrometry phosphorylation screen, potential binding partners of B7-H3 were identified by analyzing tyrosine-phosphorylation sites of NK cells, which were confronted with LN229 GBM cells silenced for B7-H3 or with control-LN229 cells presenting B7-H3. Here, CD276 is linked to glioblastoma.